KAYANNA JONAS: Open Payments
NPI 1538674619 · SOUTH OZONE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,397 in 179 payments from 12 companies in 2025. Trend: 2023 $11,067 · 2024 $36,524 · 2025 $35,397
Speaker / faculty: $20,973Consulting: $7,120Food & beverage: $5,175Travel & lodging: $2,130
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 42 | $16,934 |
| Alkermes, Inc. | 30 | $9,261 |
| Teva Pharmaceuticals USA, Inc. | 22 | $4,008 |
| E.R. Squibb & Sons, L.L.C. | 34 | $3,645 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $475 |
| ABBVIE INC. | 14 | $441 |
| Otsuka America Pharmaceutical, Inc. | 9 | $201 |
| Axsome Therapeutics, Inc. | 6 | $185 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| Lundbeck LLC | 3 | $73 |
Products named: INGREZZA, LYBALVI, UZEDY, COBENFY, CAPLYTA, ARISTADA, VRAYLAR, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
